Caisson Biotech LLC is categorized under Commercial Biotechnical Research in Austin, TX and active since 2009.
Caisson Biotech LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Thomas Harlan at the company’s single location by writing to 11412 Fm 2244 # 300, Austin, Texas TX 78738 or by phoning (512) 263-3232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Caisson Biotech LLC |
| Contact Person: | Thomas Harlan |
| Address: | 11412 Fm 2244 # 300, Austin, Texas 78738 |
| Phone Number: | (512) 263-3232 |
| Website Address: | caissonbiotech.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Caisson Biotech LLC was started in 2009 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Thomas Harlan for inquiries that concern Caisson Biotech LLC by calling the company number (512) 263-3232, as your correspondence is most welcome. Additionally, the physical location of the single location of Caisson Biotech LLC can be found at the coordinates 30.310816,-97.912976 as well as the street address 11412 Fm 2244 # 300 in Austin, Texas 78738.
For its online presence, you may visit Caisson Biotech LLC’s website at caissonbiotech.com and engage with its social media outlets through on Twitter and on Facebook.